CURRICULUM VITAE RONALD E. DOMEN, MD PERSONAL DATA ...
CURRICULUM VITAE RONALD E. DOMEN, MD PERSONAL DATA ...
CURRICULUM VITAE RONALD E. DOMEN, MD PERSONAL DATA ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>CURRICULUM</strong> <strong>VITAE</strong><strong>RONALD</strong> E. <strong>DOMEN</strong>, <strong>MD</strong><strong>PERSONAL</strong> <strong>DATA</strong>Business Address: The Penn State Milton S. Hershey Medical CenterThe Pennsylvania State University College of MedicineDepartment of PathologySection of Clinical Laboratories, H160P.O. Box 850500 University DriveHershey, PA 17033Telephone: 717-531-5116Fax: 717-531-3803E-mail: rdomen@hmc.psu.eduEDUCATION1968-1971: Youngstown State UniversityYoungstown, OH 44503Bachelor of Arts (A.B., 9/2/72)1971-1975: Universidad Autonoma de GuadalajaraFacultad de MedicinaGuadalajara, Jalisco, MexicoDoctor of Medicine (M.D., 6/12/75)POSTGRADUATE TRAINING1975-1976: Monmouth Medical Center(a major teaching affiliate of Hahnemann Medical College ofPhiladelphia)Long Branch, NJ 07740Supervised Clinical Clerkship Program (Fifth-PathwayProgram) (7/1/75 to 5/31/76)1976-1979: Saint Luke's Hospital
(a major teaching affiliate of Case Western ReserveUniversity School of Medicine)Cleveland, OH 44104Straight Medical Internship (7/1/76 to 6/30/77)Internal Medicine Residency (7/1/77 to 6/30/79)Chief Medical Resident (10/1/78 to 12/31/78)1979-1980: The Ohio State University Hospital410 W. 10th AvenueColumbus, OH 43210Fellow, Department of Medicine, Division of Hematology-Oncology; and Regular Clinical Fellow, American CancerSociety (7/1/79 to 6/30/80)1980-1982: The Ohio State University HospitalColumbus, OH 43210Clinical Pathology Residency, Department of Pathology(7/1/80 to 6/30/82)1982-1983: The Ohio State University HospitalColumbus, OH 43210Fellow, Department of Pathology, Division ofImmunohematology (Blood Banking/Transfusion Medicine)(7/1/82 to 6/30/83)EXAMINATIONS/BOARD CERTIFICATIONS/LICENSUREEducational Council for Foreign Medical Graduates (ECFMG); January 23, 1974(examination passed); completed Supervised Clinical Clerkship (Fifth-Pathway)in lieu of ECFMG certificationFederal Licensing Examination (FLEX); June 1976State Medical Licenses: Connecticut (1976, inactive); Ohio (1977, active); Maine(1982, inactive); Florida (1984, inactive); Pennsylvania (1988, active); NewJersey (1992, inactive)Diplomate, The American Board of Internal Medicine (Internal Medicine);September 9, 19802
Diplomate, The American Board of Pathology (Clinical Pathology); June 2, 1982Diplomate, The American Board of Pathology (Blood Banking/TransfusionMedicine); September 25, 1989Qualified to be the director of a laboratory accredited by ASHI (American Societyfor Histocompatibility & Immunogenetics) by the Director Training Review andCredentialing Committee (DTRC); August 21, 2008ACADEMIC AND PROFESSIONAL APPOINTMENTS1979-1980: Clinical Instructor; The Ohio State University, College ofMedicine, Department of Medicine, Division of Hematology-Oncology (7/1/79 to 6/30/80)1980-1982: Clinical Instructor; The Ohio State University, College ofMedicine, Department of Pathology (7/1/80 to 6/30/82)Staff Physician (part-time); American Red Cross BloodServices, Central Ohio Region, Columbus, OH 43205(7/1/80 to 6/30/82)1982-1984: Assistant Professor; The Ohio State University, College ofMedicine, Department of Pathology (7/1/82 to 6/30/84)Assistant Professor; The Ohio State University, School ofAllied Medical Professions, Division of Medical Technology(11/1/82 to 6/30/84)Assistant Director; Blood Bank, Transfusion and ApheresisServices, The Ohio State University Hospital, Columbus, OH(7/1/82 to 6/30/84)Consulting Staff (Clinical Pathology); Memorial Hospital ofUnion County, Marysville, OH 43040 (7/1/82 to 6/30/84)Category I status on the Graduate Faculty in the Departmentof Pathology, The Ohio State University, College ofMedicine, (9/1/82 to 2/3/84)Category II status on the Graduate Faculty in theDepartment of Pathology, The Ohio State University,College of Medicine (2/3/84 to 6/30/84)3
1984-1988: Assistant Professor; University of South Florida, College ofMedicine, Department of Pathology and LaboratoryMedicine, Tampa, FL (7/1/84 to 6/30/88)Assistant Professor; University of South Florida, College ofMedicine, Department of Internal Medicine, Tampa, FL(7/1/84 to 6/30/88)Director; Division of Immunohematology, Department ofPathology and Laboratory Medicine, University of SouthFlorida, College of Medicine (7/1/84 to 6/30/88)Chief; Blood Bank, James A. Haley Veterans AdministrationHospital, Tampa, FL 33612 (7/1/84 to 6/30/88)1985-1986: Chief; Hematology Laboratory, James A. Haley VeteransAdministration Hospital, Tampa, FL 33612 (1/1/85 to7/31/86)1985-1988: Medical Consultant; Southwest Florida Blood Bank, Tampa,FL (1/1/85 to 6/30/88)Credentialed as a member of the Graduate Faculty,University of South Florida, Tampa, FL (7/8/85 to 6/30/88)1986-1988: Chief; Blood Bank, H. Lee Moffitt Cancer Center andResearch Institute at the University of South Florida, Tampa,FL 33682-0179 (10/27/86 to 6/30/88; Founding Physician)1988-1993: Medical Director; Samuel W. Miller Memorial Blood Center,Bethlehem, PA 18017 (8/1/88 to 8/15/93)Vice President, Medical Director; Hospital Central Services,Inc. and Subsidiaries, Allentown, PA 18103 (8/1/88 to8/15/93)1989-1993: Consulting Staff (Pathology); Easton Hospital, Easton, PA18042 (3/23/89 to 8/15/93)Consulting Staff (Medicine); Saint Luke's Hospital,Bethlehem, PA 18015 (6/26/89 to 8/15/93)Consulting Staff (Pathology); Lehigh Valley Hospital,Allentown, PA 18103 (8/24/89 to 8/15/93)4
Clinical Assistant Professor; The Pennsylvania StateUniversity, College of Medicine, Department of Pathology,M.S. Hershey Medical Center, Hershey, PA 17033 (7/1/89 to6/30/93)1993-1999: Full Staff Physician; The Cleveland Clinic Foundation;Section of Blood Banking and Transfusion Medicine,Department of Clinical Pathology, Division of Pathology andLaboratory Medicine, Cleveland, OH 44195 (9/1/93 to1/31/99)Director; Viral Markers Laboratory, The Cleveland ClinicFoundation, Department of Clinical Pathology (9/1/93 to1/31/99)1994-1999: Joint Staff Appointment; Department of Hematology &Medical Oncology, Division of Medicine, The ClevelandClinic Foundation (2/25/94 to 1/31/99)1995-1997: Director, Cellular Immunology Laboratory, Department ofClinical Pathology, The Cleveland Clinic Foundation1995-1999: Associate Professor; The Ohio State University, College ofMedicine, Department of Pathology, Columbus, OH 43210(2/13/95 to 1/31/99)1995-1999: Co-Director of the Cleveland City-Wide Fellowship Programin Blood Banking and Transfusion Medicine1996-1998: Director, Bone Marrow and Stem Cell ProcessingLaboratory, Department of Clinical Pathology, The ClevelandClinic Foundation (10/10/96 to 5/27/98)1999-2006: Medical Director, Unit of Blood Banking and TransfusionMedicine (including therapeutic apheresis), Section ofClinical Laboratories, Department of Pathology andLaboratory Medicine, The Milton S. Hershey Medical Center,The Pennsylvania State University College of Medicine,Hershey, PA 17033 (2/1/99 to 6/30/06)1999-2006: Director, Peripheral Blood Progenitor Cell Collection Facility,Bone Marrow Transplant Program, Milton S. HersheyMedical Center, Penn State University College of Medicine(8/24/99 to 6/30/06)5
1999-2002: Associate Professor of Pathology, Department of Pathology,The Pennsylvania State University, College of Medicine(2/1/99 to 6/30/02)2000-2005: Director, Residency Program, Department of Pathology, TheMilton S. Hershey Medical Center, The Pennsylvania StateUniversity College of Medicine (7/1/00 to 6/30/05)2001-2002: Associate Professor of Medicine (joint appointment in theDivision of Hematology and Oncology), Department ofMedicine, The Pennsylvania State University, College ofMedicine (1/1/01 to 6/30/02)2002-present:2002-present:2002-present:2005-present:Professor of Pathology, Department of Pathology, ThePennsylvania State University, College of Medicine (7/1/02-present)Professor of Medicine (joint appointment in the Division ofHematology and Oncology), Department of Medicine, ThePennsylvania State University, College of Medicine (7/1/02-present)Professor of Humanities (joint appointment), Department ofHumanities, The Pennsylvania State University, College ofMedicine (7/1/02-present)Associate Dean for Graduate Medical Education, Penn StateUniversity College of Medicine/Milton S. Hershey MedicalCenter, Hershey, PA (3/1/05-present)2006 Acting Interim Co-Chair (for Clinical Pathology), Penn StateUniversity College of Medicine/Milton S. Hershey MedicalCenter, Hershey, PA (1/4/06 – 5/15/06))2006 Acting Chief, Clinical Pathology and Hospital Laboratories,Penn State University College of Medicine, Milton S.Hershey Medical Center, Hershey, PA (1/4/06-6/25/06)2006-2008 Associate Director, Histocompatibility (HLA) Laboratory,Penn State University College of Medicine/Milton S. HersheyMedical Center, Hershey, PA (4/1/06-8/29/08)2007-presentProgram Director, Blood Banking/Transfusion MedicineFellowship, Division of Clinical Pathology, Department ofPathology, Penn State University College of Medicine/MiltonS. Hershey Medical Center, Hershey, PA (7/2007-present)6
2008-present2008-presentDesignated Institutional Official (DIO) for the ACGME, PennState University College of Medicine/Milton S. HersheyMedical Center, Hershey, PA (7/2/08-present)Medical Director, Histocompatibility (HLA) Laboratory, PennState University College of Medicine/Milton S. HersheyMedical Center, Hershey, PA (8/29/08-present)2010-2011 Interim Chief, Division of Clinical Pathology, and Director ofClinical Laboratories, Department of Pathology, Penn StateCollege of Medicine/Milton S. Hershey Medical Center,Hershey, PA (8/23/10-6/30/2011)PROFESSIONAL SOCIETY MEMBERSHIPS (CURRENT)Fellow, American College of Physicians (FACP)Fellow, College of American Pathologists (FCAP)Member, American Association of Blood Banks (AABB)Member, American Society for ApheresisMember, American Society for Bioethics and HumanitiesMember, The Samuel Hinkle Society (Penn State University College of Medicine)Member, American Society for Histocompatibility and Immunogenetics (ASHI)HOSPITAL, COLLEGE OF MEDICINE, DEPARTMENTAL, AND COMMUNITYCOMMITTEESThe Ohio State UniversityTransfusion Committee; The Ohio State University Hospital, Columbus, OH(1982-1984)Undergraduate Education Committee; Department of Pathology, The Ohio StateUniversity, Columbus, OH (1982-1984)Computer Committee; Department of Pathology, The Ohio State University,Columbus, OH (1982-1984)7
Member of the Team to Coordinate and Establish the Bone Marrow TransplantService at The Ohio State University Hospital (1983-1984)University of South FloridaTransfusion Committee; James A. Haley Veterans Administration Hospital,Tampa, FL (1984-1988, Acting Chairman 1987, Chairman 1988)Tissue and Blood Committee; H. Lee Moffitt Cancer Center and ResearchInstitute, Tampa, FL (1986-1988)Miller Blood Center, Bethlehem, PATransfusion Committee; Saint Luke's Hospital, Bethlehem, PA (1988-1993)Blood Usage Review Committee; Easton Hospital, Easton, PA (1989-1993)Transfusion Review Committee; Lehigh Valley Hospital, Allentown, PA (1989-1993)The Cleveland ClinicMedical Records and Statistics Committee; The Cleveland Clinic Foundation,Cleveland, OH (1993-1997)Division Education Committee; Division of Pathology and Laboratory Medicine,The Cleveland Clinic Foundation, Cleveland, OH (1993-1998)Bone Marrow Donor Program Advisory Committee; American Red Cross BloodServices, Northern Ohio Region, Cleveland, OH (1994-1997)General Medical Science Review Committee (a Research Program Committee ofthe Institutional Review Board); The Cleveland Clinic Foundation, Cleveland, OH(1994-1998)Blood Usage Review Consultant; The Cleveland Clinic Foundation, Cleveland,OH (1994-1997)Task Force Committees for the Ethics Committee; The Cleveland ClinicFoundation, Cleveland, OH (1994-1999)Rights of Conscience Task Force (Chair)Resource Allocation Task ForceRevision of Ethics Policies/Manual Task ForceControversial Issues Task ForceInnovative Interventions Task Force8
Transplantation Sub-Committee of the Ethics Committee; The Cleveland ClinicFoundation, Cleveland, OH (1994-1999)Ethics Committee; The Cleveland Clinic Foundation, Cleveland, OH (1994-1999)Stewart Fellowship Advisory Committee; The Cleveland Clinic Foundation,Cleveland, OH (1995-1999)Quality Committee; American Red Cross Blood Services, Northern Ohio Region,Cleveland, OH (1995-1998)Introduction to Clinical Medicine (ICM) Academic Program Committee, The OhioState University, College of Medicine, Columbus, and The Cleveland ClinicFoundation, Cleveland, OH (1996)Resident Appeal Task Force; Division of Education, The Cleveland ClinicFoundation, Cleveland, OH (June 1996)Genetics and Reproductive Issues Sub-committee of the Ethics Committee; TheCleveland Clinic Foundation, Cleveland, OH (1996-1998)Institutional Review Board; The Cleveland Clinic Foundation, Cleveland, OH(Alternate Member, Sept. 1996-August 1997; Full Member August 1997-Oct.1998)Chair, Transplantation Sub-Committee of the Ethics Committee, The ClevelandClinic Foundation, Cleveland, OH (1997-1998)Penn State College of Medicine/Penn State Milton S. Hershey Medical CenterPast (inactive) Appointments/MembershipsBoard of Directors; Central Pennsylvania Blood Bank, Hummelstown, PA (1999-2006; Board Member of the Year, 2004)Medical Advisory Committee; Central Pennsylvania Blood Bank, Hummelstown,PA (1999-2006; Chair, July 2000-June 2001; and July 2004-June 2005)Blood Usage Committee; Milton S. Hershey Medical Center, Penn StateUniversity College of Medicine, Hershey, PA (1999-2006)Pediatric Intensive Care Committee; Milton S. Hershey Medical Center, PennState University College of Medicine, Hershey, PA (1999-2005)9
Promotion to Associate Professor Committee; Department of Pathology, M.S.Hershey Medical Center, Penn State University College of Medicine, Hershey,PA (1999 – 2000)Reimbursement/Billing/Compliance Design Team; Milton S. Hershey MedicalCenter, Penn State University College of Medicine, Hershey, PA (1999 – 2000)Corporate Compliance Oversight Committee; Milton S. Hershey Medical Center,Penn State University College of Medicine, Hershey, PA (2000 – 2005)Standards of Performance Team (World Class Care Initiative); Milton S. HersheyMedical Center, Penn State University College of Medicine, Hershey, PA (2000)Pharmacy and Therapeutics Committee; Milton S. Hershey Medical Center, PennState University College of Medicine, Hershey, PA (September 2000 –September 2005)Executive Committee; Department of Pathology and Laboratory Medicine, MiltonS. Hershey Medical Center, Penn State University College of Medicine, Hershey,PA (July 2000 – June 2005; January 2006 – May 2006)Medical Student Selection Committee (Team II); The Pennsylvania StateUniversity College of Medicine, Hershey, PA (Sept. 2000 – June 2005)Search Committee for Chair, Department of Obstetrics & Gynecology, PennState University College of Medicine, Milton S. Hershey Medical Center,Hershey, PA (2001 – 2002)Association of Pathology Chairs (APC) Pathology Honors Society SelectionCommittee, Department of Pathology and Laboratory Medicine, Milton S.Hershey Medical Center, Penn State University College of Medicine, Hershey,PA (2002 – 2005)Search Committee for Chair, Department of Medicine, Penn State UniversityCollege of Medicine, Milton S. Hershey Medical Center, Hershey, PA (2003 -2004)Academic Progress Committee (Years 3 & 4), Penn State University College ofMedicine, Hershey, PA (April 15, 2003)Medical Staff Executive Committee, Penn State University College of Medicine,Milton S. Hershey Medical Center, Hershey, PA (January 2004 – June 2004;January 2006 – May 2006)10
Academic Team (of the Unified Campus Teams), Penn State University Collegeof Medicine/Milton S. Hershey Medical Center, Hershey, PA (September 2004 –September 2008)Resident Ombudsman, Penn State University College of Medicine/Milton S.Hershey Medical Center, Hershey, PA (January 2005 – September 2005)Academic, Research, and Human Resources Teams Sub-Group on FacultyAdvancement and Career Development, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (January 2005 – March2005)Patients, Physicians, and Society Course Task Force, Penn State UniversityCollege of Medicine, Hershey, PA (2005)Chair, Finance Sub-Committee of the Graduate Medical Education Committee,Penn State University College of Medicine/Milton S. Hershey Medical Center,Hershey, PA (November 2005 – 2009)Academic Mission Subgroup of the Strategic Planning Task Force, Penn StateUniversity College of Medicine/Milton S. Hershey Medical Center, Hershey, PA(September 2006 – December 2006)Strategic Medical Education Committee, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (May 2005 – August2006)Teaching Skills Needs Assessment Committee, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (August 2007 – March2008)Oversight Board for Simulation Laboratory, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (2007 – 2009)Diversity Office Task Force, Penn State University College of Medicine/Milton S.Hershey Medical Center, Hershey, PA (August 2007 – June 2009)Patient Safety Culture Strategy Team, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (January 2009 –August 2009)LCME Steering Committee, Penn State University College of Medicine/Milton S.Hershey Medical Center, Hershey, PA (May 2008 – February 2010)11
LCME Task Force Committee on Academic Environment, Penn State UniversityCollege of Medicine/Milton S. Hershey Medical Center, Hershey, PA (Sept. 2008– February 2010)Woodward Endowment Steering Group, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (January 2010 – July2011)Physician’s Assistant Program Implementation Task Force, Penn StateUniversity College of Medicine/Milton S. Hershey Medical Center, Hershey, PA(January 2010 – July 2011)Search Committee for Associate Dean for Clinical Curriculum, Penn StateCollege of Medicine, Hershey, PA (2010)Search Committee for Associate Dean for Continuing Medical Education, PennState College of Medicine/Milton S. Hershey Medical Center, Hershey, PA (2010)Search Committee for Associate Dean for Diversity, Penn State College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (2010-11)Team Training Advisory Group, Penn State University College of Medicine/MiltonS. Hershey Medical Center, Hershey, PA (June 2009 – July 2011)Vice Chair, Graduate Medical Education Committee, Penn State HersheyMedical Center and College of Medicine, Hershey, PA (March 2005 – June 2012)Current (Active) Appointments/MembershipsEthics Committee; Milton S. Hershey Medical Center, Penn State UniversityCollege of Medicine, Hershey, PA (August 1999 – present)Quality Improvement Committee; Department of Pathology, Division of ClinicalPathology, Milton S. Hershey Medical Center, Penn State University College ofMedicine, Hershey, PA (1999 – present)Residency Directors Committee; The Milton S. Hershey Medical Center, PennState University College of Medicine, Hershey, PA (July 2000 – present; Chair,May 2005 – present)Doctors Kienle Center for Humanistic Medicine, Department of Humanities, PennState University College of Medicine, Hershey, PA (May 2004 – present)Graduate Medical Education Committee, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (March 2005 –present)12
Organizational Goals Oversight Team, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (June 2009 – present)Academic Team (of the Unified Campus Teams), Penn State University Collegeof Medicine/Milton S. Hershey Medical Center, Hershey, PA (September 2009 –present)Awards Committee, Department of Pathology, Penn State Hershey MedicalCenter and College of Medicine, Hershey, PA (2009 – present)Interdisciplinary Course Committee (ICC) for Clinical Learning & Competencies(CLC-712, -721, and -722), Penn State College of Medicine, Hershey, PA (2009– present)Finance Sub-Committee of the Graduate Medical Education Committee, PennState Hershey Medical Center and College of Medicine, Hershey, PA (2009 –present)Conflict of Interest Review Committee, Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA (January 2010 –present)Membership Sub-Committee of the Ethics Committee, Penn State HersheyMedical Center and College of Medicine, Hershey, PA (2010 – present)Education Sub-Committee of the Ethics Committee, Penn State Hershey MedicalCenter and College of Medicine, Hershey, PA (2010 – present)Laboratory Utilization Committee, Department of Pathology, Penn State HersheyMedical Center and College of Medicine, Hershey, PA (2010 – present)Physician Advisory Council to the Dean (Department of Pathology faculty liaisonto the Dean, Penn State College of Medicine) (July 2010 – present)Faculty Liaison and Chief Oversight for the Housestaff Quality Council, PennState Hershey Medical Center and College of Medicine, Hershey, PA (July 2010– present)Quality Physician Liaison (for Department of Pathology to Quality Services),Penn State College of Medicine/Milton S. Hershey Medical Center, Hershey, PA(September 2010 – present)Donor Advocate Team for Kidney Transplant Program, Penn State HersheyMedical Center, Hershey, PA (May 2011 – present)14
Interdisciplinary Course Committee (ICC) for Hematology (HEM-721), Penn StateCollege of Medicine, Hershey, PA (January 2012 – present)Chair, Sizing Sub-Committee of the Graduate Medical Education Committee,Penn State Hershey Medical Center and College of Medicine, Hershey, PA(January 2012 – present)Chair, Graduate Medical Education Committee, Penn State Hershey MedicalCenter and College of Medicine, Hershey, PA (June 2012 – present)NATIONAL AND STATE COMMITTEES AND ACTIVITIESEthics Committee; American Association of Blood Banks (1987-1991)Scientific Program Committee; Co-Chairman for the 1990 joint PennsylvaniaAssociation of Blood Banks and Mid-Atlantic Association of Blood Banks MeetingExecutive Committee (Board of Directors); Pennsylvania Association of BloodBanks (1990-1993)Continuing Education Committee; American Association of Blood Banks (1990-1993)Board of Directors; Society of Hemapheresis Specialists (1991-1993)Scientific, Medical and Technical Committee; Council of Community BloodCenters (CCBC; now, America’s Blood Centers) (1991-1993)Bylaws Committee; American Association of Blood Banks (1991-1995)Ad Hoc National Marrow Donor Program (N<strong>MD</strong>P) Advisory Committee; Councilof Community Blood Centers (CCBC; now, America’s Blood Centers) (1992-1993)Transfusion Transmitted Viruses Ancillary Committee to the TransfusionMedicine Resource Committee; College of American Pathologists (Jan. 1992-Dec. 1999)Ad Hoc Ethics Committee; Ohio Association of Blood Banks (1995-1997)Observer of Record (for the College of American Pathologists) to the NationalCommittee for Clinical Laboratory Standards (NCCLS) Subcommittee onProtection of Laboratory Workers (1995-1998)15
Board of Directors; Ohio Association of Blood Banks (1995-1997)Creutzfeldt-Jakob Disease (CJD) Policy Drafting Work Group; AmericanAssociation of Blood Banks (1996)Transfusion Practices Committee; American Association of Blood Banks (1996-1997)Ad Hoc FDA Liaison Committee; American Association of Blood Banks; Liaisonmember for the College of American Pathologists (1997-1999)Ethics Committee; Ohio Association of Blood Banks (Formerly an Ad HocCommittee; 1995-1998, Founding Member)Standards Committee; American Association of Blood Banks (1997-1999)Ad Hoc HCV Lookback Committee (Hospital Subgroup); American Association ofBlood Banks (1998)Ethics Committee; American Association of Blood Banks (1998-2000)Board of Directors; Pennsylvania Association of Blood Banks (PABB) (2000-2002)Ad Hoc Tissue and Organ Procurement Committee; College of AmericanPathologists (2000-2003)The Program Directors Section (PRODS) of the Association of Pathology Chairs(APC), Inc. (2000-2005)Ethics Committee; The Program Directors Section (PRODS) of the Association ofPathology Chairs (APC), Inc. (2000-2005)Publications Committee; College of American Pathologists (2001)Council on Public Affairs; College of American Pathologists (Jan. 2002-Dec.2003)Membership Committee (of the Council on Membership and Public Affairs);College of American Pathologists (January 2004-December 2005)AABB Resident Transfusion Medicine Curriculum Task Force, AABB (AmericanAssociation of Blood Banks) (October 2005 – April 2007)16
Member Development Committee (of the Council on Membership andProfessional Development); College of American Pathologists (January 2006-December 2009)Histocompatibility/Identity Testing Committee; College of American Pathologists(January 2008 – December 2009)Pathology Fellowship Application Task Group of the Association of PathologyChairs and PRODS (March 2008 – July 2008)OPTN/UNOS Ethics Committee (At-Large Member); United Network for OrganSharing (July 2009 – July 2011)Group on Resident Affairs (GRA), American Association of Medical Colleges(AAMC) (June 2005 – present)Apheresis Medicine Inter-Societal Liaison Group (American Society for Apheresis[ASFA]) (2008 – present)American Society for Apheresis (AFSA) Residents and Fellows Training Ad HocCommittee (2008 – present)Blood Utilization Committee Task Force of the University HealthSystemConsortium (UHC) (June 2010 – present)Apheresis Physicians Committee (American Society for Apheresis [ASFA])(2010-present)Graduate Medical Education Committee; College of American Pathologists(January 2011 – present)Appointed as Ethics Consultant to the following AABB committees (October 2011– present): AABB Donor History Questionaire – HPC Task Force; CellularTherapies Standards Program Unit; Blood Banks and Transfusion ServicesStandards Program Unit; Molecular Testing Laboratories Standards ProgramUnit; and, Audit/Ethics CommitteeCouncil on Membership & Professionalism Development; College of AmericanPathologists (January 2012 – present)EDITORIAL BOARD AND REVIEW RESPONSIBILITIESAd Hoc Manuscript Review17
TransfusionCleveland Clinic Journal of MedicineClinical Infectious DiseasesJournal of the American Medical Association (JAMA)American Journal of Clinical PathologyArchives of Pathology & Laboratory MedicineConsultant (Consultations in Primary Care)American Journal of Obstetrics and GynecologyHaematologicaVox SanguinisTransfusion MedicineAmerican Journal of HematologyEditorial BoardsAssociate Editor; Cleveland Clinic Journal of Medicine (1996-1999)Editorial Board; CAP TODAY, College of American Pathologists (2001)Contributing Editor; CAP TODAY (Clinical Pathology abstracts section), Collegeof American Pathologists (2001-2005)Editorial Board; American Journal of Clinical Pathology (2002-present)Editorial Board; Archives of Pathology & Laboratory Medicine (2003-present)Editorial Board; The Open Clinical Chemistry Journal (2008-present)Poetry Editor; International Journal of Healthcare & Humanities (December 2009-present)Editorial Board; Journal of Transfusion (2010-present)18
EXECUTIVE AND ADMINISTRATIVE EDUCATIONEffective Management/The Manager as Leader; Seminar provided by William D.Hitt, PhD of the Battelle Memorial Institute, Columbus, OH over 1-2 days inNovember 1989 in Philadelphia, PA.The In Search of Excellence Seminar; CareerTrack (Boulder, CO); Bethlehem,PA (December 9, 1992)Building and Teaching the Therapeutic Relationship; Bruce Hubbard StewartFellows were specially invited for the First Cleveland Clinic professionaldevelopment course (September 15, 1998)The Impressions Service Excellence Train-the-Trainer Program; PennState/Milton S. Hershey Medical Center, Hershey, PA (April 15-16, 1999)Leadership Development: Achieving Our Vision Through Strategic Direction;Penn State/Milton S. Hershey Medical Center, Hershey, PA (June 25, 2001)Leadership Development: Quality and Performance Improvement in a NewCulture of Responsibility; Penn State/Millton S. Hershey Medical Center,Hershey, PA (December 6, 2001)Leadership Development: The Leader’s Role in Building Commitment; PennState/Milton S. Hershey Medical Center, Hershey, PA (May 20, 2002)Leadership in Action seminar; The Center for Leadership Development, PennState/Milton S. Hershey Medical Center, Hershey, PA (October 1, 2002)Leadership Development: Masterful Coaching: A Five-Step Method to MaximizeOur Potential; The Center for Leadership Development, Penn State/Milton S.Hershey Medical Center, Hershey, PA (November 7, 2002)“The Tough Work of Leadership.” The Center for Leadership Development,Penn State/Milton S. Hershey Medical Center, Hershey, PA (Course Leader:Wiley W. “Chip” Souba, <strong>MD</strong>, ScD, MBA) (Monthly four-hour sessions fromJanuary 2003 to November 2003)“Leadership That Makes A Difference.” The Center for Leadership Development,Penn State/Milton S. Hershey Medical Center, Hershey, PA (June 23, 2003)19
“Teaching, Promoting and Assessing Professionalism: A Core Competency forMedical Education.” Penn State/Milton S. Hershey Medical Center, Hershey, PA(July 21, 2003)“Professionalism: Taking the Next Steps.” Penn State/Milton S. HersheyMedical Center, Hershey, PA (April 1, 2004)“Leading Curricular Change: Skills and Strategies for Success.” Tufts HealthCare Institute, Cambridge, MA (September 9-10, 2004)“GME Leadership Development Course: Part I: Practical Approaches toInstitutional Accreditation.” Course developed and presented by the Group onResident Affairs (GRA) of the Association of American Medical Colleges (AAMC).Course held in Austin, Texas (April 22-23, 2006)“GME Leadership Development Course: Part II: Managing the Institution’s GMEEnterprise.” Course developed and presented by the Group on Resident Affairs(GRA) of the Association of American Medical Colleges (AAMC). Course held inChicago, Illinois (September 15-16, 2006)“GME Leadership Development Course: Part III: Advanced GME Topics andLeadership Skills.” Course developed and presented by the Group on ResidentAffairs (GRA) of the Association of American Medical Colleges (AAMC). Courseheld in Memphis, Tennessee (April 21-22, 2007)COURSES TAUGHT/DIRECTED (MEDICAL STUDENT AND CME COURSES)Pathology 503: Medical Technology (Spring 1983); The Ohio State UniversitySchool of Allied Medical Professions, Columbus, Ohio (Co-Director with JohnNeff, <strong>MD</strong>)Pathology 503: Medical Technology (Spring 1984); The Ohio State UniversitySchool of Allied Medical Professions, Columbus, Ohio (Co-Director with JohnNeff, <strong>MD</strong>)Clinical-Laboratory Hematology (BMS 6610; Laboratory Medicine, Part I);University of South Florida College of Medicine, Tampa, Florida (Co-Director withDrs. Robert C. Hartmann, Wang, and Judish) (November 1984-January 1985)Laboratory Medicine: Clinical-Laboratory Hematology (BMS 6610); University ofSouth Florida College of Medicine, Tampa, Florida (Co-Director with Robert C.Hartmann, <strong>MD</strong>) (February-April 1986)20
Laboratory Medicine: Clinical-Laboratory Hematology (BMS 6610); University ofSouth Florida College of Medicine, Tampa, Florida (Director) (1987)Laboratory Medicine: Clinical-Laboratory Hematology (BMS 6610); University ofSouth Florida College of Medicine, Tampa, Florida (Director) (1988)Introduction to Clinical Medicine (ICM) (CMICGECC3); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Blood Banking/TransfusionMedicine component presented to thirteen third year medical students (Director:J. Walton Tomford, <strong>MD</strong>). 16 August 1995. Student contact: 1.5 hours.Introduction to Clinical Medicine (ICM); The Ohio State University College ofMedicine (Columbus, Ohio campus). Teaching/laboratory session presented toapproximately 25 third year medical students (Subsection Director: CarmenJulius, <strong>MD</strong>). 18 August 1995. Student contact: 2 hours.Bioethics (internal medicine didactic sessions/curriculum); The Ohio StateUniversity College of Medicine (The Cleveland Clinic campus). Small groupfacilitator and participant in bioethics case presentations and discussions to thirdyear medical students (Coordinator and co-presentor: Jacquelyn Slomka, PhD,Department of Bioethics, The Cleveland Clinic). There were 5 sessions(approximately 2 hours each) given to different groups of students during 1995,1996, and 1997.Introduction to Clinical Medicine (ICM) (CMICGECC3); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Blood Banking/TransfusionMedicine component presented to seven third year medical students (Director: J.Walton Tomford, <strong>MD</strong>). 14 August 1996. Student contact: 2 hours.Introduction to Clinical Medicine (ICM); The Ohio State University College ofMedicine (Columbus, Ohio campus). Teaching/laboratory session presented toapproximately 27 third year medical students (Subsection Director: CarmenJulius, <strong>MD</strong>). 21 August 1996. Student contact: 1.5 hours.Bioethics Mini-Module (Independent Study Program); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Facilitator and coparticipant(Course coordinator: Jacquelyn Slomka, PhD, Department ofBioethics, The Cleveland Clinic). Three sessions (approximately 2 hours each).December 1996.Course Director and principal organizer for yearly, one-day symposium entitledTransfusion Medicine Update, held at The Cleveland Clinic, Cleveland, Ohio in1994, 1995, and 1996.Introduction to Clinical Medicine (ICM) (CMICGECC3); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Blood Banking/Transfusion21
Medicine component presented to sixteen third year medical students (Director:J. Walton Tomford, <strong>MD</strong>). 13 August 1997. Student contact: 1.5 hours.Bioethics Mini-Module (Independent Study Program); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Facilitator and coparticipant(Course coordinator: Jacquelyn Slomka, PhD, Department ofBioethics, The Cleveland Clinic). 9 December 1997. Student contact: 3 hours.Introduction to Clinical Medicine (ICM) (CMICGECC3); The Ohio State UniversityCollege of Medicine (The Cleveland Clinic campus). Blood Banking/TransfusionMedicine component presented to eighteen third year medical students (Director:J. Walton Tomford, <strong>MD</strong>). 18 August 1998. Student contact: 1.5 hours.Patients, Physicians, and Society: Humanities (Course 713/714); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Anne Hunsaker Hawkins, PhD). One of six small group instructors (16 students).Ten two hour sessions taught from December 1999-February 2000.Lecturer in the Hematology Course (HEM 721; Course Directors: J.O. Ballard,<strong>MD</strong> and Thomas Nifong, <strong>MD</strong>; then, Thomas Nifong, <strong>MD</strong>) given to the secondyear medical students, Penn State University College of Medicine. Studentcontact: 1 hour in the years 2000-01-02-03-04-05-06.Patients, Physicians, and Society: Clinical Ethics (Course 723/724); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Michael Green, <strong>MD</strong>). One of the small group facilitators (17 students). Six 1.5hours sessions taught from March 2000-April 2000.Patients, Physicians, and Society: Humanities (Course 713/714); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Anne Hunsaker Hawkins, PhD). One of seven small group instructors (18students). Ten two hour sessions taught from December 2000-February 2001.Patients, Physicians, and Society: Humanities (Course 713/714); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Anne Hunsaker Hawkins, PhD). One of eight small group instructors (16students). Twelve two-hour sessions taught from December 2002-February2003.Patients, Physicians, and Society: Humanities (Course 713/714); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Anne Hunsaker Hawkins, PhD). One of eight small group instructors (16students). Twelve two-hour sessions taught from December 2003 – February2004.22
Patients, Physicians, and Society: Humanities (Course 713/714); Penn StateUniversity College of Medicine, Department of Humanities (Course Director:Philip K. Wilson, PhD). One of eight small group instructors (16 students).Twelve two-hour sessions taught from December 2004 – February 2005.Organized a two-hour workshop for Program Directors on managing the ACGMEcompetency mandate (included outside lecturer). Penn State University Collegeof Medicine/Milton S. Hershey Medical Center, Hershey, PA. December 1, 2006.Co-director and co-organizer for a half-day workshop/seminar on “IntegratingResidents in Quality Improvement.” Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA. April 11, 2007.Organized a half-day workshop/seminar on “Legal Issues in Graduate MedicalEducation.” Penn State University College of Medicine/Milton S. HersheyMedical Center. Hershey, PA. November 16, 2007.Patients, Physicians, and Society: Medical Humanities (Course 713/714); PennState University College of Medicine, Department of Humanities (CourseDirector: Philip K. Wilson, PhD). One of eight small group instructors (20students). Eleven of the twelve two-hour sessions taught from January 2008 –March 2008.Organized a half-day workshop/seminar on “Encouraging, Developing, andSuppporting Healthcare Quality Improvement Work by Learners.” Penn StateUniversity College of Medicine/Milton S. Hershey Medical Center, Hershey, PA.May 20, 2008.Patients, Physicians, and Society: Medical Humanities (Course 713/714); PennState University College of Medicine, Department of Humanities (CourseDirector: Philip K. Wilson, PhD; and, J.O. Ballard, <strong>MD</strong>). One of eight small groupinstructors (18 students) (14 hours of small group contact). Twelve two-hoursessions from January 2010 – April 2010.Lecturer in the Hematology Course (HEM 721; Course Directors: J.O. Ballard,<strong>MD</strong> and Michael G. Bayerl, <strong>MD</strong>) given to the second year medical students, PennState University College of Medicine. Student contact: 1 hour. August 23, 2011.Organized a two-hour workshop on “Residency Program Director’s Workshop:Best Practices.” May 3, 2012OTHER ADMINISTRATIVE/EDUCATIONAL/RESEARCH ACTIVITIES23
Establishment of in vitro growth of canine erythroid colonies (CFU-E) through theculture of canine bone marrow cells by the plasma clot technique. Evaluation ofagonists of cyclic-AMP (cholera toxin and vasoactive intestinal polypeptide) on invitro growth of CFU-E. The Ohio State University College of Medicine (1979-1980)Development and writing of a cancer chemotherapy protocol for metastatic coloncarcinoma for patients within The Ohio State University Hospital (InterdisciplinaryOncology Unit protocol number 8006) (1979-1980)Establishment and setting up of the Blood Bank and Transfusion Service at thenewly constructed H. Lee Moffitt Cancer Center and Research Institute at theUniversity of South Florida College of Medicine, Tampa, FL. Recognized as aFounding Physician (1985-1988).Inspector for the American Association of Blood Banks as part of their Inspectionand Accreditation Program for blood banks and transfusion services (1986-1996)Establishment of a community-based donor plateletpheresis program, acommunity-based blood irradiation service, and a community-based specialservices program (autologous and directed donor programs) at the MillerMemorial Blood Center, Bethlehem, PA (1988-1993)Medical and administrative assistance to the former ARUP-Cleveland ClinicReference Laboratory (a for-profit laboratory within the Division of Pathology andLaboratory Medicine of The Cleveland Clinic Foundation) (1993-1994)Inspector for the College of American Pathologists Laboratory AccreditationProgram (1994-1998)Bruce Hubbard Stewart Fellow; The Cleveland Clinic Foundation, Cleveland, OH(1996-1997). Established in 1984 to recognize the art of medicine, and torecognize and encourage the development and enhancement of humanistic andethical qualities in the practice of medicine. The Stewart Fellowship Programyearly recognizes a select few individuals (both physician and non-physician)within The Cleveland Clinic for their humanistic and artistic qualities in thepractice of medicine and in the humane care of patients (I am only the secondpathologist selected since fellowship inception in 1984).Member of the lead research team (at The Cleveland Clinic) for the NationalPhase III Perioperative Diaspirin Cross-Linked Hemoglobin (DCLHb ) Trial (1996-1998) (Acknowledgement noted in: Schubert A, Przybelski RJ, Eidt JF, LaskyLC, Marks KE, et al. Diaspirin-crosslinked hemoglobin reduces blood transfusionin noncardiac surgery: a multicenter, randomized, controlled, double-blindedtrial. Anesth Analg 2003;97:323-332)24
Guest Faculty Editor for Wild Onions (Issue 15), an annual publication funded byThe Doctors Kienle Center for Humanistic Medicine, Penn State UniversityCollege of Medicine, Department of Humanities, Hershey, PA. Wild Onions is ajournal of poetry, prose works, photography, and artwork created by members ofthe whole Hershey Medical Center community (2001).Board Member of the Year (2004), Central Pennsylvania Blood Bank,Hummelstown, PA (presented May 9, 2005).“Outstanding Mentor” recognition by The Penn State College of Medicine Classof 2008.Mentor for faculty in the Junior Faculty Development Program at Penn StateMilton S. Hershey Medical Center/Penn State College of Medicine, Hershey, PA.o 2008-2009: Wilson Po, <strong>MD</strong>, Department of Anesthesiology (ObstetricAnesthesia Curriculum for CA-1 Residents)o 2009-2010: Nicole Swallow, <strong>MD</strong>, Department of Medicine (Residents asTeachers Curriculum for Internal Medicine Residents)TELEVISION AND RADIO PRESENTATIONS“Blood Donation and the Miller Blood Center.” Talk-show format taped at theTwin County Cable Television studios as part of their “Community Spotlight”program. Appeared with Fran Chizeck, Director, Donor Resources, Miller BloodCenter, Bethlehem, PA. 7 August 1989 (30 minutes).“Blood Donation.” Talk-show, viewer phone-in format presented live on cabletelevision channel 69, Allentown, PA as part of their “Talk With Your Doctor”series. Appeared with Fran Chizeck (Director, Donor Resources, Miller BloodCenter) and Bala Carver, <strong>MD</strong> (Director, Transfusion Medicine, Lehigh ValleyHospital Center, Allentown, PA). 18 January 1990 (1 hour).“Blood Donation and the Miller Blood Center.” Talk-show on radio station WGPA(1100 AM), Bethlehem, PA as part of their “Valley Forum” series. Appeared withFran Chizeck, Director, Donor Resources, Miller Blood Center. 2 October 1990(30 minutes).“Current Trends in Blood Transfusion and Collection.” Live talk-show, listenerphone-in radio program on station WEST (1400 AM), Easton, PA as part of their“Voice of the People” series. 6 March 1990 (30 minutes).“Blood Donation and Blood Diseases.” Talk-show, viewer phone-in formatpresented live on channel 69 cable television, Allentown, PA as part of their “TalkWith Your Doctor” series. 10 January 1991 (1 hour).25
“Blood Donation and Apheresis.” Talk-show, listener phone-in radio programpresented live on radio station WEST (1400 AM), Easton, PA as part of their“Voice of the People” show. 5 February 1991 (30 minutes).“Blood Transfusion and Donation.” Talk-show, listener phone-in presented liveon radio station WEST (1400 AM), Easton, PA as part of their “Voice of thePeople” series. 15 October 1991 (30 minutes).“Issues in Blood Banking.” Talk-show, listener phone-in live radio showpresented on radio station WEST (1400 AM), Easton, PA as part of their “Voiceof the People” series. 16 June 1992 (30 minutes).Numerous “spot” radio and television appearances in the Lehigh Valley(Allentown, Bethlehem, and Easton) Pennsylvania, and Harrisburg, Pennsylvaniaareas.“Ethical Aspects of Transfusion and Pathology with a particular focus onInformed Consent.” Interviewed for the TV/Webcast program “Matter andBeyond” based in New Jersey. 13 August 2007. To be broadcast April 1, 2008at: http://www.ebru.tv/en/ebrutv/LifestyleCulture/Matter_And_Beyon/c.310.htmlINVITED PRESENTATIONS (SELECTED)“Donor Incentives: An Ethics Dialogue.” Lecturer/facilitator at Ethical Issues inTransfusion Medicine workshop at the 1996 Annual Meeting of the OhioAssociation of Blood Banks, Dayton, OH. 9 May 1996.“Blood Component Therapy: Review and Update.” Medical Grand Rounds, andVisiting Professor, Akron General Medical Center, Akron, OH. 24 July 1996.“Practical Implementation and Use of the Gel Test.” Lecture presented at the42nd Annual Meeting of the Michigan Association of Blood Banks, Troy, MI. 12September 1996.“The Use of Drugs in Normal Donors: An Ethics Dialogue.” Lecturer/facilitator atEthical Issues in Transfusion Medicine workshop at the 1997 Annual Meeting ofthe Ohio Association of Blood Banks, Cleveland, OH. 10 April 1997.“Transfusion Medicine and Organ Transplantation.” Lecture presented at the1997 Annual Meeting of the Ohio Association of Blood Banks, Cleveland, OH.11 April 1997.26
“Transfusion Medicine Fellowship: Current Training and Educational Issues.”Lecture given at the SBB/Transfusion Medicine Fellow/Pathology ResidentTraining workshop at the 1997 Annual Meeting of the American Association ofBlood Banks, Denver, CO. 19 October 1997.“Autologous Blood Transfusion for Surgical Procedures.” Lecture presented aspart of a three-day symposium, Survey of Current Issues in Surgical Anesthesia,The Cleveland Clinic Foundation, Cleveland, OH. 7 November 1997.“Practices and Challenges in Transfusion Medicine.” Lecture presented to theDepartment of Pathology, University of California, Davis Medical Center,Sacramento, CA. 18 March 1998.“Patient Confidentiality and the Electronic Media: An Ethical Perspective.”Lecturer/Panelist at the program entitled, Patient Confidentiality and theElectronic Media: Ethical and Legal Perspectives, jointly sponsored by TheCenter for Healthcare Ethics, and Employers Health Alliance, Cincinnati, OH. 15May 1998.“Interesting and Unusual Adverse Reactions to Transfusion.” Lecture presentedto the Department of Pathology, Oregon Health Sciences University, Portland,OR. 3 June 1998.“Unusual Adverse Reactions to Transfusion.” Lecture presented to the RoswellPark Cancer Institute, Buffalo, NY. 7 August 1998.Panelist in the first annual College of American Pathologists (CAP) FoundationPierre W. Keitges, <strong>MD</strong>, Memorial Program on Medical Ethics (Sr. RosemaryFlanigan, PhD, Director of Ethics, Community Development, and Education atthe Midwest Bioethics Center, Kansas City, MO moderated this SocraticDialogue). Held at the 1998 Fall Meeting of the CAP/ASCP, Washington, DC.19 October 1998.“Ethical Issues in Transfusion Medicine.” American Society of ClinicalPathologists (ASCP) teleconference presented to approximately 60 sites in theUnited States, Canada, and Puerto Rico. 2 December 1998.“Ethics and Transfusion Medicine.” American Association of Blood Banks(AABB) teleconference presented to 65 sites across North America and Europe (Iwas one of three presenters). 1 December 1999.“Clinical Applications and Ethical Issues in the Use of Stem Cells for GeneTransfer.” Invited lecture presented at a workshop/conference entitled, Updateon Stem Cells: Identification, Harvesting and Clinical Applications, sponsored bythe University of Medicine & Dentistry of New Jersey, School of Health RelatedProfessions, Newark, NJ, in collaboration with the New Jersey Organ and Tissue27
Sharing Network (Course Director/Coordinator: Elaine M. Keohane, PhD).Approximately 30-40 participants in attendance. 11 November 2000.“Selected Ethical Issues in Transfusion Medicine.” Lecture presented to theannual meeting of the Canadian Society for Transfusion Medicine (a jointmeeting with the Canadian Blood Services and Hema-Quebec) held at London,Ontario, Canada from May 10-13, 2001. The conference theme was TransfusionMedicine in the 21 st Century. Approximately 327 individuals were registered. 11May 2001.“Medicine and Poetry: The Physician as Poet.” Interactive two-hour seminarpresented at the NEH Summer Institute: Medicine, Literature, and Culture,organized and directed by Anne Hunsaker Hawkins, PhD, Department ofHumanities, Penn State University College of Medicine, Hershey, PA; and,Susan Squier, PhD, Department of Women’s Studies, Penn State University,University Park, PA. The Institute was held at Penn State University College ofMedicine/Milton S. Hershey Medical Center, Hershey, PA during the month ofJuly 2002. There were 25 participants from various educational institutions in theUnited States. 23 July 2002.“Professionalism.” Lecture and panel discussion presented at the Developing theCompetency Toolbox at the APC/PRODS (Association of PathologyChairs/Pathology Program Directors) GME Session at the Summer Meeting heldin Park City, Utah. 25 July 2002.“Professionalism in Pathology: Implementing Change.” Lecture presented at theannual meeting of the Northeast Section of the Association of Pathology Chairs(APC) (Director/Organizer: Fred Gorstein, <strong>MD</strong>; Jefferson MedicalCollege/Thomas Jefferson University Hospital). Wild Dunes, Isle of Palms, SouthCarolina. 28 September 2002.“Ethics in the Trenches.” Panelist and presenter at the CAP Foundation PierreKeitges, <strong>MD</strong>, Memorial Program on Medical Ethics at the College of AmericanPathologists (CAP) Annual Meeting, Phoenix, Arizona. Co-members of the panelincluded Michael G. Bissell, <strong>MD</strong>, Gene N. Herbek, <strong>MD</strong>, and Jack Bierig, JD. 19September 2004.“Use of G-CSF for Granulocyte Donors.” Invited lecturer and panelist at theconference Safeguarding Adult and Pediatric Stem Cell Donors: Basic Science,Clinical and Ethical Issues, Arlington, Virginia (Conference Chair: EdwardSnyder, <strong>MD</strong>, Yale University). Conference sponsors included NHLBI, YaleUniversity, AABB, ASBMT, ASFA, ISCT, and others. 21 – 22 September 2004.“Disclosure of Errors: Ethics and Risks.” Invited lecturer and panelist at thisconference presented at the 2004 Annual Meeting of the American Association ofBlood Banks (AABB), Baltimore, <strong>MD</strong> (Director: Emily B. Rossiter,28
MT(ASCP)RAC; Moderator: Terry Perlin, PhD; Co-presenters/panelists: RichardP. Kidwell, JD; and, John Banja, PhD). Approximately 300 attendees. 25October 2004.“Blood Avoidance I: A Primer on the Medical, Legal, Ethical and ReligiousAspects.” Participant in this American Society for Clinical Pathology (ASCP)teleconference presented to approximately 50 sites (approximately 300attendees). Co-presenters included, Roslyn Yomtovian, <strong>MD</strong>; Martin L. Smith,STD; and, Laurel Hyle, JD, MPH. My presentation included medical aspects ofblood optimization (rational use) of blood products. 28 September 2005.“Blood Avoidance II: Problem Solving and Continuing Challenges.” Participantin this American Society for Clinical Pathology (ASCP) teleconference presentedto approximately 25 sites. Co-presenters included, Roslyn Yomtovian, <strong>MD</strong>;Martin L. Smith, STD; and Laurel Hyle, JD, MPH. Presentations by individualfaculty were followed by a panel-type format with questions from the audience. 2November 2005.“Ethics: Preimplantation Genetic Diagnosis (PGD) and Savior Siblings.” Invitedlecture presented at the 2006 Annual Spring Meeting of the American Society forClinical Laboratory Science – Pennsylvania; King of Prussia, PA. 4 May 2006.“Focus on Fellowships: Reigning in the Free-for-All.” Invited panelist at the 2008Annual Meeting of the Association of Pathology Chairs (APC)/PRODS (ProgramDirectors in Pathology). Moderator: James Crawford, <strong>MD</strong>, PhD; Additionalpanelists included: Gayle Winters, <strong>MD</strong> and Michael Talbert, <strong>MD</strong>. ColoradoSprings, CO. 17 July 2008.“The Ethical Challenge: Committing and Staying Committed to a Fellowship Slot(Policing or Not).” Invited leader of this workshop at the 2008 Annual Meeting ofthe Association of Pathology Chairs (APC)/PRODS (Program Directors inPathology). Colorado Springs, CO. 17 July 2008.“Informed Consent for Donation: Whole Blood and Apheresis (IncludingProgenitor Cell and WBC Donors).” Co-presenter (with Kathleen Sazama, <strong>MD</strong>,JD; <strong>MD</strong> Anderson Cancer Center, Houston, TX) in this American Society forClinical Pathology (ASCP) teleconference presented to approximately 17 sites inthe United States and Canada. 4 November 2008.“Informed Consent for Blood Donation.” Invited lecture presentation to the 35 thmeeting of the Advisory Committee on Blood Safety and Availability (U.S.Department of Health and Human Services), Rockville, <strong>MD</strong>. 16 December 2008.“The Informed Consent Process in Whole Blood Donation.” Invited lecturepresentation to the 100 th meeting the Food and Drug Administration (FDA) BloodProducts Advisory Committee (BPAC) meeting. Gaithersburg, <strong>MD</strong>. 29 April 2011.29
A complete listing of more than 350 lectures/presentations, and courses taught, to medicalstudents, residents, and other physician and non-physician groups is available on request.BIBLIOGRAPHYABSTRACTS1. Roberts WH, Kennedy MS, Domen RE, Wanger GP. Acute copper deficiencyin patients undergoing plasma exchange. Ohio Association of Blood Banks,Annual Meeting, Columbus, OH. April 1-2, 1982.2. Roberts WH, Kennedy MS, Domen RE, Wanger GP. Acute copper deficiencyin patients undergoing plasma exchange. Proceedings of International Society ofArtificial Organs International Symposium; Plasmapheresis: TherapeuticApplications and Techniques. Cleveland, OH. April 1982.3. Kennedy MS, Jones L, Domen RE. Plasma exchange comparing membranefiltration to discontinuance flow centrifugation. Ohio Association of Blood Banks,Annual Meeting, Cleveland, OH. March 23-25, 1983.4. Domen RE, Keehn WH, Calero A. Acute hemolytic transfusion reaction dueto anti-A 1 . Blood 1986;68 (suppl. 1):295a.5. Domen RE, Ramirez G, Calero A. Red cell alloimmunization in chronic renaldisease patients. Blood 1986;68 (suppl. 1):296a.6. Domen RE, Gilbert DM. Red cell agglutination caused by vancomycin.Transfusion 1987;27:514.7. Domen RE, Gilbert DM. An easy and effective in-house competencytesting/quality assurance program. Transfusion 1987;27:561.8. Williams L, Domen RE. Effects of vancomycin on red blood cell interactions.American Society for Microbiology, combined regional microbiology meetings,Southeastern, Florida, and Kentucky-Tennessee Branches. Orlando, FL.November 12-14, 1987.9. Williams L, Domen RE. Effect of vancomycin on red blood cell serologicaltesting. Blood 1987;70 (suppl. 1):116a.10. Domen RE, Thronson HA Jr. The graduate education of academicastronomers. Bulletin of the American Astronomical Society 1988;20:650.30
11. Williams L, Domen RE. Effect of vancomycin on red blood cell interactions.Presented by L. Williams at the 29th Annual National Student Research Forum,Galveston, TX. April 6-8, 1988. Won First Place, Graduate Student Division,for overall clinical excellence.12. Williams L, Domen RE. Effect of vancomycin on red blood cell serologicaltesting. Presented at the 42nd Annual Meeting of the Florida Association ofBlood Banks, Tampa, FL. June 2-4, 1988.13. Gilbert D, Williams L, Domen RE. The importance of consulting previouspatient records. Presented at the 42nd Annual Meeting of the FloridaAssociation of Blood Banks, Tampa, FL. June 2-4, 1988.14. Gilbert D, Domen RE. Technical and administrative aspects of a case studyinvolving multiple antibodies. Presented at the 42nd Annual Meeting of theFlorida Association of Blood Banks, Tampa, FL. June 2-4, 1988.15. Gilbert DM, Domen RE, Leparc GF. An effective portable donor drive whichincluded plateletpheresis and educational exhibits on transfusion medicine.Transfusion 1988;28:425.16. Williams L, Domen RE, Rowlands DT Jr. Vancomycin-red blood cellinteractions are mediated by zeta potential. Presented by L. Williams at the 30thAnnual National Student Research Forum, Galveston, TX. April 13-15, 1989.Won First Place, Graduate Student Division, for excellence in clinicalresearch.17. Williams L, Domen RE. Zeta potential and vancomycin-red blood cellinteractions. Transfusion 1989;29:33S.18. Clarke A, Stefaniak L, Domen R, Carver B, Mundt K. Anti-k reactive at roomtemperature. Presented at the joint annual meeting of the PennsylvaniaAssociation of Blood Banks/Mid-Atlantic Association of Blood Banks, Hunt Valley,<strong>MD</strong>. April 26-28, 1990.19. Garratty G, Arndt P, Clarke A, Domen R. Fatal hemolysis associated withan IgM anti-En a warm autoagglutinin. Presented at the International Society ofBlood Transfusion/American Association of Blood Banks Joint Congress, LosAngeles, CA. November 10-15, 1990. Book of Abstracts, page 154, 1990.20. Garratty G, Nance S, Domen R. Fatal immune hemolytic anemia due tocefotetan. Presented at the International Society of Blood Transfusion/AmericanAssociation of Blood Banks Joint Congress, Los Angeles, CA. November 10-15,1990. Book of Abstracts, page 32, 1990.31
21. Domen RE, Stefaniak LA. The reinstatement of anti-HBc positive blooddonors. Accepted for a platform (oral) presentation at the International Society ofBlood Transfusion/American Association of Blood Banks Joint Congress, LosAngeles, CA. November 10-15, 1990. Book of Abstracts, page 210, 1990.22. Arndt P, Clarke A, Domen R, Clear J, Groncy P, Garratty G. Two cases ofsevere warm type autoimmune hemolytic anemia associated with IgM anti-En aand anti-Pr. Transfusion 1991;31:29S.23. Domen RE. Blood donation and individuals arrested for prostitution.Transfusion 1992;32:29S.24. Hoeltge GA, Domen RE. Red cell antibodies encountered at a majorreferral hospital. Presented at the Annual Meeting of the Ohio Association ofBlood Banks, Columbus, OH. April 20-22, 1994.25. Domen RE, Rybicki LA, Hoeltge GA. An analysis of autologous blood donormotivational factors. Accepted for a platform (oral) presentation at the 47thAnnual Meeting of the American Association of Blood Banks, San Diego, CA.November 12-17, 1994. Transfusion 1994;34:95S.26. Yen-Lieberman B, Schindler S, Hatch D, Roberto A, Gaddis L, Domen R.Effects of sample preparation, dilutions and matrix addition on the performanceof FDA approved HIV-1 tests. Presented at the Tenth Annual Conference onHuman Retrovirus Testing of the Association of State and Territorial PublicHealth Laboratory Directors, Reno, NV. March 6-9, 1995.27. Grewal ID, Domen RE. Autoanti-B antibody in a group B patient with afactor VIII inhibitor. Presented at the Annual Meeting of the Ohio Association ofBlood Banks, Toledo, OH. May 3-5, 1995.28. Yen-Lieberman B, Schindler S, Hatch D, Roberto A, Gaddis L, Domen R.Effects of sample preparation, dilutions and matrix addition on the performanceof FDA approved HIV-1 tests. Presented at the 95th General Meeting of theAmerican Society for Microbiology, Washington, D.C. May 21-25, 1995.29. Grewal ID, Domen RE, Hirschler NV. The value of shared donor deferralregistries. Accepted for a platform (oral) presentation at the 48th Annual Meetingof the American Association of Blood Banks, New Orleans, LA. November 11-15, 1995. Transfusion 1995;35:66S.30. Slomka J, Domen R. Do no harm and don’t order anything that ends in a‘gram.’ Presented at the 1997 Annual Meeting of the Society for AppliedAnthropology held in cooperation with the Society for Medical Anthropology, theCouncil on Nursing and Anthropology, and the Political Ecology Society. Seattle,Washington. March 4-9, 1997.32
31. Domen RE. Preoperative autologous blood donation by patients undergoingsurgery for severe epilepsy. Transfusion 1997;37(suppl.):25S.32. Domen RE. Adverse transfusion reactions to autologous blood: incidenceand evaluation at a large academic hospital. Transfusion 1997;37(suppl.):44S.33. Domen RE. Autologous blood donation after solid organ transplantation.Proceedings of the 50th Annual Meeting of the American Association of BloodBanks, page 148S.34. Domen R, Hoeltge G. Alloanti-D antibody formation following transfusion inpatients with the weak D (D u ) phenotype. Blood 1997;90(suppl. 1, part 2):130b.35. Domen R, Pohlman B, Kalaycio M, Serafino S, Andresen S, Goormastic M,Bolwell B. Autologous blood donation prior to allogeneic bone marrow harvest.Blood 1997;90(suppl. 1, part 2):325b.36. Volk EE, Domen RE, Hall GS, Yen-Lieberman B, Bankowski MJ. DNAamplification by polymerase chain reaction applied to the detection of bacterialcontamination in platelet concentrates. American Journal of Clinical Pathology1998;109:472.37. McCarron KF, Domen RE, Bringelsen K. A fatal case of autoimmunehemolytic anemia temporally related to DTP vaccination. Transfusion1998;38(suppl.):41S.38. Dykstra A, Hoeltge G, Jacobs M, Miller J, Domen R, Yomtovian R. Plateletbacterial contamination (PBC) rate is surveillance method (SM) dependent.Transfusion 1998;38(suppl.):104S.39. Javeed M, Nifong TP, Domen RE, Rybka WB. Durable response tostaphylococcal protein A immunoadsorption treatment in life-threateningrefractory autoimmune hemolysis. Blood 2000;96(Part 2):6b.40. Freiberg AS, Kees-Folts D, Domen RE, Astacio HN, Mauger DT. Incidenceand risk factors for hemolytic complications of anti-D therapy for ITP. Blood2000;96(Part 1):253a.41. Freiberg AS, Mauger DT, Domen RE. Duration of the positive directantiglobulin (Coombs’) test after intravenous Rh(D) immune globulin. Blood2001;98 (Part 2):104b.42. Ostrov BE, Groh BP, Domen RE. The use of the staphylococcal Aimmunoadsorption column (Prosorba) to treat severe, treatment resistant juvenilerheumatoid arthritis. Pediatric Rheumatology Online Journal; Vol 1, Issue 3,33
June 2003; abstract number 65.(http://www.pedrheumonlinejournal.org/June/171.htm)43. Uemura T, Riley TR, Khan A, Schreibman I, Hollenbeak C, Kwon O,Ghahramani N, Reeves B, Domen RE, Zander DS, Kadry Z. Monitoring ofimmune function for treatment of post-transplant de novo malignancy. Posterpresentation at the American Transplant Congress 2008 meeting, Toronto,Ontario, Canada; May 31 – June 4, 2008. Abstract number 1128. Published in:American Journal of Transplantation 2008;8(s2):479.44. Domen RE, Casey H, Gaspari J. Correlation of HLA donor specific antibody(DSA) titers with the Luminex mean fluorescence intensity (MFI). Posterpresentation at The American Society for Histocompatibility and Immunogenetics(ASHI) 2008 annual meeting, Toronto, Ontario, Canada; October 27-31, 2008.Abstract number 56-P. Published in: Human Immunology 2008;69(s1):S35.45. Domen RE, Casey H, Tyler J, Gaspari J, Khan A, Uemura T, Kadry Z.Antibody mediated kidney rejection associated with a DQA1-specificalloantibody. Oral presentation (by, J. Tyler) at The American Society forHistocompatibility and Immunogenetics (ASHI) 2008 annual meeting, Toronto,Ontario, Canada; October 27-31, 2008. Abstract number 48-W. Published in:Human Immunology 2008;69(s1):S123.46. Kang J, Domen RE. A retrospective analysis of two plasma exchangeprotocols in the treatment of antibody-mediated rejection following renal allografttransplantation. Oral presentation (by, J. Kang) at the American Society forApheresis (AFSA) 30 th annual meeting, San Diego, CA. May 20-23. 2009.Published in: Journal of Clinical Apheresis 2009;24:57.47. Kang J, Domen RE. PRODS apheresis survey results. Invited oralpresentation of apheresis survey of pathology residency program directorspresented (by J. Kang) at the Graduate Medical Education Forum at theAmerican Society for Apheresis (AFSA) 30 th annual meeting, San Diego, CA.May 20-23, 2009.48. Liang JJ, Domen RE, Uemura T, Khan A, Kugler K, Bruggeman R, RuggieroFM, Abt AB, Kadry Z, Abendroth CS. Diagnostic utility of C4dimmunohistochemical staining in pancreas allograft biopsies and correlation withHLA donor specific antibodies. Presented at the 2010 annual meeting of theUnited States and Canadian Academy of Pathology, Washington, DC. March 20-26, 2010.49. Wehler A, Domen RE, Bongiovanni MB, Davis J, Shike H. Predicting plateletflow cytometric crossmatch compatibility by HLA antibody median flourescenceintensity. Presented at the 2010 annual meeting of the Association of ClinicalScientists, San Antonio, TX. May 12-16, 2010.34
50. Fisher CL, Casey HA, Bement TL, Lachance ME, Habig DF, Goss KJ,Gaspari JL, Domen RE, Shike H. Observed increase in MFI of donor specificantibody upon implementation of DTT serum treatment. Poster presentation atthe 36 th annual meeting of the American Society for Histocompatibility &Immunogenetics (ASHI), Hollywood, FL. September 26-30, 2010. Published in:Human Immunology 2010;71(suppl. 1):S58.51. Kumer LH, Mowery CL, Fisher CL, Malec LA, Bement TL, Gaspari JL,Domen RE, Shike H. Pronase-induced false positive T-cell flow XM observed incertain patient-donor combinations. Poster presentation at the 36 th annualmeeting of the American Society for Histocompatibility & Immunogenetics(ASHI), Hollywood, FL. September 26-30, 2010. Published in: HumanImmunology 2010;71(suppl. 1):S38.52. Casey HA, Kumer LH, Mowery CL, Malec LA, Maybach MA, Tyler JL, FeltDK, Hess JA, Gaspari JL, Domen RE, Shike H. “Natural” HLA antibodies in thepatients on UNOS kidney or pancreas wait list. Poster presentation at the 36 thannual meeting of the American Society for Histocompatibility & Immunogenetics(ASHI), Hollywood, FL. September 26-30, 2010. Published in: HumanImmunology 2010;71(suppl. 1):S20.53. George MR, Nifong TP, Ehmann C, Wells J, Shike H, Domen RE, Welch T,Bears L, Castellani WJ. Technical aspects of therapeutic leukapheresis in CMLduring pregnancy. Poster presentation at the 64 th annual meeting of the AABB,San Diego, CA. October 22-25, 2011. Published in: Transfusion2011;51(suppl.):85A.54. Gaspari JL, Blair LT, Lee H, Tyler J, Casey HA, Domen RE, Shike H. A newC*03:02 variant that escaped LABType SSO detection. Poster presentation atthe 37 th annual meeting of the American Society for Histocompatibility &Immunogenetics (ASHI), New Orleans, LA. October 17-21, 2011. Published in:Human Immunology 2011;72(suppl. 1):S101.55. Gaspari JT, Malec LA, Maybach MA, Goss KJ, Habig DF, Bement TL, TylerJL, Casey HA, Domen RE, Kumer LH, Shike H. No DTT treatment for flowcrossmatch (XM). Poster presentation at the 37 th annual meeting of the AmericanSociety for Histocompatibility & Immunogenetics (ASHI), New Orleans, LA.October 17-21, 2011. Published in: Human Immunology 2011;72(suppl. 1):S62.56. Gaspari JL, Casey, Kumer LH, Fisher CL, Lachance ME, Felt DK, Hess JA,Mowery CL, Domen RE, Shike H. Predicting crossmatch (XM) results; ASHIproficiency testing (PT) results as a main source of assay correlation. Posterpresentation at the 37 th annual meeting of the American Society forHistocompatibility & Immunogenetics (ASHI), New Orleans, LA. October 17-21,2011. Published in: Human Immunology 2011;72(suppl. 1):S62.35
EDITORIALS AND COMMENTARIES1. Wanger GP, Domen RE. A laboratory year for clinicians? Journal of theAmerican Medical Association 1982;247:1119.2. Domen RE. Commentary: Perioperative recombinant human erythropoietinin hip replacement. Annals of Internal Medicine 1993;119 (suppl. 2):46. (ACPJournal Club, Sept/Oct 1993).3. Domen RE. JA-1994 Comprehensive Transfusion Medicine Survey: DataAnalysis and Critique. College of American Pathologists, Northfield, IL.April/May 1994.4. Domen RE. Commentary: Erythropoietin reduced the need for homologousblood transfusion. Annals of Internal Medicine 1995;122 (suppl. 2):36. (ACPJournal Club, March/April 1995).5. Domen RE. The confidential unit exclusion (CUE). Analysis, critique, andcommentary of supplementary questions to the 1994 DC-C, W1-C, and W2-Csurveys. College of American Pathologists, Northfield, IL. 1995.6. Domen RE. Medical confidentiality in the electronic era. The ClevelandClinic Connection 1996;6(1):10.7. Domen RE. Question & Answer: What should a laboratorian expect to seewhen doing hepatitis profile testing on someone who has been vaccinatedagainst hepatitis B? CAP Today 1996;10:80.8. Domen RE. Blood donation, donor incentives and ethics. Ohio Associationof Blood Banks Newsletter, January 1997, pp. 2-3.9. Domen RE. Do genes make the man? An ethical analysis and response ona case of testicular feminization. Bio-Quarterly (Bioethics in Ohio) 1997;6(1):30-32.10. Domen RE. JA-1999 Comprehensive Transfusion Medicine Survey, DataAnalysis and Critique. College of American Pathologists, Northfield, IL.July/August 1999.11. Domen RE. Ethical issues raised by mandatory testing of autologous blooddonors. AABB News August 2000:7 and 22.36
12. Domen RE. Editorial. Warm red blood cell autoantibodies and the directantiglobulin test revisited. American Journal of Clinical Pathology 2004;122:673-674.13. Domen RE, Simons RJ. Engaging residents in quality improvement.ACGME Bulletin, November 2007; pages 15-16.14. Domen RE. Invited Book Review. Living Donor Organ Transplantation(edited by, Rainer W.G. Gruessner and Enrico Benedetti. New York, NY:McGraw-Hill, Inc., 2008. ISBN-13: 978-0-0714-5549-7). JAMA 2008;300:1592-1593.15. Domen RE. Invited Book Review. Human Tissue in Transplantation andResearch: A Modal Legal and Ethical Donation Framework. (By, David Price.New York, NY: Cambridge University Press, 2009. ISBN: 978-0-5217-0954-5).JAMA 2011;305:719-720.BOOKSMacpherson CR, Domen RE, Perlin T (editors). Ethical Issues in TransfusionMedicine. Bethesda, <strong>MD</strong>: AABB Press, 2000 (ISBN NO: 1-56395-138-X).BOOK CHAPTERS1. Domen RE. Immune Hemolysis. In, Hurst JW (editor-in-chief), Medicine forthe Practicing Physician. 4th edition. Stamford: Appleton & Lange, 1996:828-831.2. Domen RE, Smith ML. Confidentiality and Informed Consent Issues inTransfusion Medicine. In, Macpherson CR, Domen RE, Perlin TM (editors),Ethical Issues in Transfusion Medicine. Bethesda, <strong>MD</strong>: AABB Press, 2000;39-54.3. Domen RE. Blood Product Transfusions in the Hematologic Malignancies.In, Sekeres MA, Kalaycio ME, Bolwell BJ (editors). Clinical MalignantHematology. New York: McGraw-Hill, 2007;1127-1138.4. Domen RE, Sazama K. Informed Consent: The Donor Perspective. In,Stowell CP, Sazama K (editors). Informed Consent in Blood Transfusion andCellular Therapies: Patients, Donors, and Research Subjects. Bethesda, <strong>MD</strong>:AABB Press, 2007:113-137.37
5. Domen RE. Ethical Aspects of Informed Consent: American Models. In,Maniatis A, Van der Linden P, Hardy JF, (editors). Alternatives to BloodTransfusion in Transfusion Medicine. 2nd edition. Oxford: Blackwell Publishing,2011;523-530.NONRESEARCH LETTERS TO THE EDITOR1. Domen RE. Glucagonoma and diabetic ketoacidosis? Archives of InternalMedicine 1980;140:1397-198.2. Domen RE. Paleopathological evidence of rheumatoid arthritis. Journal ofthe American Medical Association 1981;246:1899.3. Domen RE, Roberts WH. Trace metals and plasma exchange. Lancet1986;2(8515):1096.4. Domen RE. Graduate medical education in pathology revisited. Archives ofPathology and Laboratory Medicine 1987;111:686.5. Domen RE. Transfusion practices among anesthesiologists. Vox Sanguinis1988;54:127.6. Domen RE. Vancomycin-induced cytopenias. Archives of Internal Medicine1992;152:413-414.7. Domen RE. The antiquity and origins of rheumatoid arthritis. Journal of theAmerican Medical Association 1992;268:2649.8. Domen RE. Lab Directors. CAP Today 1992;6:10.9. Domen RE. Perilous times in pathology education. American Journal ofClinical Pathology 1993;99:216.10. Stagno SJ, Slomka J, Domen RE. Response to “Death with Dignity?”editorial. Journal [The OSU College of Medicine and Public Health Journal]1998;47(2):16.11. Domen RE. Nonaccredited medical education in the United States. NewEngland Journal of Medicine 2000;343:1122-1123.12. Domen RE. Humanities education. American Journal of Nursing2003;103(7):117.13. Domen RE. Doctors who are educated abroad. The Chronicle of HigherEducation 2005;52(15):A43. (December 2, 2005).38
14. Domen RE, Wehler A. An examination of professional and ethical issues inthe fellowship application process in pathology – reply. Human Pathology2008;39:1552-1553.RESEARCH LETTERS TO THE EDITOR1. Domen RE, Smith RE, Sagone AL. Lithium carbonate [and pure red cellaplasia]. Archives of Internal Medicine 1981;141:268.2. Domen RE, Straumfjord JV Jr. Using the MSBOS in academic institutions.Pathologist 1986;40 (3):5-6.3. Domen RE, Williams L, Gilbert DM. Preparation of leukocyte-depleted redcells by filtration. Transfusion 1987;27:504.4. Domen RE. Labile coagulation factor activity in pooled random donor plateletconcentrates. Southern Medical Journal 1988;81:418.5. Domen RE, Williams L. Use of the Sepacell filter for preparing white celldepletedred cells. Transfusion 1988;28:506-507.6. Domen RE, Hnat H, Panasiuk M. Autologous blood donation by patients withcardiovascular disease. Vox Sanguinis 1992;63:137.7. Domen RE. The ethics of paid versus volunteer blood donation. Journal ofMedical Ethics 1994;20:269-270.8. Domen RE. Promotion and tenure policies. American Journal of ClinicalPathology 2001;115:936-937.OTHER CREATIVE WORKSOver 35 poems published in literary journals/magazines and anthologies.PEER-REVIEWED PUBLICATIONS1. Domen RE, Tang P, Harshman KV. Granular cell myoblastoma of theesophagus after irradiation for carcinoma. Southern Medical Journal1979;72:1207-1209.39
2. Domen RE, Shaffer MB Jr, Finke J, Sterin WK, Hurst CB. The glucagonomasyndrome: report of a case. Archives of Internal Medicine 1980;140:262-263.3. Roberts WH, Domen RE, Wanger GP, Kennedy MS. Acute copper deficiencyin patients undergoing plasma exchange. In, Nose Y, Malchesky PS, Smith JW,Krakauer RS (editors): Plasmapheresis: Therapeutic Applications and NewTechniques. New York: Raven Press, 1983:395-398. (Published paper fromconference proceedings)4. Kennedy MS, Domen RE. Therapeutic apheresis: applications and futuredirections. Vox Sanguinis 1983;45:261-277.5. Domen RE. Transfusion therapy of the oncology patient. LaboratoryMedicine 1984;15:251-255.6. Domen RE, Kennedy MS, Jones LL, Senhauser DA. Hemostatic imbalancesproduced by plasma exchange. Transfusion 1984;24:336-339.7. Roberts WH, Domen RE, Walters MI. Changes in calcium distribution duringtherapeutic plasmapheresis. Archives of Pathology and Laboratory Medicine1984;108:881-883.8. Domen RE. Discovery of the Rh red blood cell antigen. Archives ofPathology and Laboratory Medicine 1986;110:162-164.9. Saba SR, Domen RE. Coagulation and immunology. Clinics in LaboratoryMedicine 1986;6:157-165.10. Domen RE. The single-unit transfusion. The Journal of the Florida MedicalAssociation 1986;73:855-857.11. Domen RE, Grattan J. Efficacy of performing red-cell antibody elutions inpatients with a positive direct antiglobulin test. Vox Sanguinis 1986;51:324-326.12. Domen RE, Ramirez G. Red cell alloimmunization in chronic renal failurepatients undergoing hemodialysis. Nephron 1988;48:284-285.13. Domen RE, Thronson HA Jr. On the graduate schools of universityastronomers. Publications of the Astronomical Society of the Pacific1988;100:641-645.14. Domen RE, Calero A, Keehn WH. Acute hemolytic transfusion reaction dueto anti-A 1 . Laboratory Medicine 1988;19:739-740.15. Williams L, Domen RE. Vancomycin-induced red cell aggregation.Transfusion 1989;29:23-26.40
16. Gilbert DM, Domen RE. Case report: ABO discrepancy due to vancomycincomplicating a transfusion reaction investigation. Immunohematology1989;5:119-120.17. Domen RE, Horowitz S. Vancomycin-induced neutropenia associated withanti-granulocyte antibodies. Immunohematology 1990;6:41-43.18. Williams L, Domen RE. Zeta potential and vancomycin-red blood cellinteractions. Archives of Pathology and Laboratory Medicine 1990;114:1262-1263.19. Domen RE, Clarke A. Case reports: red blood cell autoantibodiesmimicking alloantibodies. Immunohematology 1991;7:98-101.20. Garratty G, Nance S, Lloyd M, Domen R. Fatal immune hemolytic anemiadue to cefotetan. Transfusion 1992;32:269-271.21. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red celltransfusions and alloimmunization: experience with 6996 antibodies detected ina total of 159,262 patients from 1985 to 1993. Archives of Pathology andLaboratory Medicine 1995;119:42-45.22. Domen RE. Paid versus volunteer blood donation in the United States: ahistorical review. Transfusion Medicine Reviews 1995;9:53-59.23. Domen RE. Infectious disease marker testing of the autologous blooddonor: a case study in clinical ethics. Archives of Pathology and LaboratoryMedicine 1995;119:807-810.24. Domen RE, Rybicki LA, Hoeltge GA. An analysis of autologous blood donormotivational factors. Vox Sanguinis 1995;69:110-113.25. Domen RE. The confidential unit exclusion and allogeneic blood donation:results from supplementary questions to the donor center and viral markerssurveys of the College of American Pathologists. Archives of Pathology andLaboratory Medicine 1995;119:1007-1011.26. Domen RE. A survey of ethics committees in national medical organizationsin the United States. HEC Forum [HealthCare Ethics Committee Forum]1995;7:333-338.27. Domen RE. Preoperative autologous blood donation: clinical, economic,and ethical issues. Cleveland Clinic Journal of Medicine 1996;63:295-300.41
39. Domen RE. Infectious disease testing related to organ and tissuetransplantation: results from a national laboratory survey. American Journal ofInfection Control 1999:27:275-278.40. O’Hara JF, Sprung J, Klein EA, Dilger JA, Domen RE, Peidmonte MR.Utilization of preoperative autologous blood donation in patients undergoingradical retropubic prostatectomy. Urology 1999;54:130-134.41. Domen RE, Yen-Lieberman B, Nelson KA, Chua J, Sholtis W, Tyus H, IsadaCM. Use of an HBV-DNA hybridization assay in the evaluation of equivocalhepatitis B virus tests in solid organ donors. Progress in Transplantation(formerly, Journal of Transplant Coordination) 2000;10:42-46.42. Domen RE. Policies and procedures related to weak D phenotype testingand Rh immune globulin administration: results from supplementary questions tothe Comprehensive Transfusion Medicine Survey of the College of AmericanPathologists. Archives of Pathology & Laboratory Medicine 2000;124:1118-1121.43. Domen RE. Medical ethics in transfusion medicine: a focus on the issue ofinformed consent. Blood Therapies in Medicine 2000;1:11-16.44. Lenahan SE, Domen RE, Silliman CC, Kingsley CP, Romano PJ.Transfusion-related acute lung injury secondary to biologically active mediators:report of a case. Archives of Pathology & Laboratory Medicine 2001;125:523-526.45. Downes KA, Domen RE, McCarron KF, Bringelsen KA. Acute autoimmunehemolytic anemia following DTP vaccination: report of a fatal case and review ofthe literature. Clinical Pediatrics 2001;40:355-358.46. Kees-Folts D, Abt AB, Domen RE, Freiberg AS. Renal failure after anti-Dglobulin treatment of idiopathic thrombocytopenic purpura. Pediatric Nephrology2002;17:91-96.47. Domen RE. Ethical and professional issues in pathology: a survey ofcurrent issues and educational efforts. Human Pathology 2002;33:779-782.(Accompanying Editorial comment: Gorstein F. Professionalism in pathology.Human Pathology 2002;33:777-778.)48. Javeed M, Nifong TP, Domen RE, Rybka WB. Durable response tocombination therapy including staphylococcal protein A immunoadsorption in lifethreateningrefractory autoimmune hemolysis. Transfusion 2002;42:1217-1220.43
49. Nifong TP, Domen RE. Oxygen saturation and Hemoglobin A content inpatients with sickle cell disease undergoing erythrocytapheresis. TherapeuticApheresis 2002;6:390-393.50. Nifong TP, Ehmann WC, Mierski JA, Domen RE, Rybka WB. Favorableoutcome after infusion of coagulase-negative Staphylococci-contaminatedperipheral blood hematopoietic cells for autologous transplantation. Archives ofPathology & Laboratory Medicine 2003;127:e19-e21.51. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of273 consecutive reactions. Archives of Pathology & Laboratory Medicine2003;127:316-320.52. Domen RE, Smith ML. Professionalism and ethics in transfusion medicine:a focus on medical errors and patient safety. Blood Therapies in Medicine2003;3:42-48.53. Domen RE. Medicine and the arts: Night Owl, by M. Wyrebek;commentary by Ronald E. Domen. Academic Medicine 2004;79:184-185.54. Domen RE. Ethical issues in transfusion medicine: a focus on the safetyof blood and hematopoietic stem cell donation. Current Hematology Reports2005;4:465-469.55. Fung MK, Crookston KP, Wehrli G, Domen R, Lopez-Plaza I, Davenport R,Gottschall J, Spitalnik S for the AABB Taskforce on Transfusion MedicineResident Curriculum. Commentary: A proposal for curriculum content intransfusion medicine and blood banking education in pathology residencyprograms. Transfusion 2007;47:1930-1936.56. Domen RE, Wehler AB. An examination of professional and ethical issuesin the fellowship application process in pathology. Human Pathology2008;39:484-488.57. Alaishuski LA, Grim RD, Domen RE. The informed consent process inwhole blood donation. Archives of Pathology and Laboratory Medicine2008;132:947-951.58. Domen RE. Ethics and narrative medicine: who owns the story? TheInternational Journal of Healthcare & Humanities 2009;4(4):2-9 (Fall 2009).59. Uemura T, Riley TR, Khan A, Hollenbeak C, Schreibman I, Ghahramani N,Reeves B, Domen RE, Zander DS, Kadry Z. Immune functional assay forimmunosuppressive management in post-transplant malignancy. ClinicalTransplantation 2011; 25:E32-37.44
60. Domen RE. The physician as poet. The International Journal ofHealthcare & Humanities 2011;6(6):2-7 (Fall 2011)45
Change language